Success Metrics

Clinical Success Rate
100.0%

Based on 41 completed trials

Completion Rate
100%(41/41)
Active Trials
1(2%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
31
66%
Ph phase_1
3
6%
Ph phase_2
13
28%

Phase Distribution

3

Early Stage

13

Mid Stage

31

Late Stage

Phase Distribution47 total trials
Phase 1Safety & dosage
3(6.4%)
Phase 2Efficacy & side effects
13(27.7%)
Phase 3Large-scale testing
31(66.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

41 of 41 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

47

all time

Status Distribution
Active(1)
Completed(41)
Other(5)

Detailed Status

Completed41
unknown5
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
47
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (6.4%)
Phase 213 (27.7%)
Phase 331 (66.0%)

Trials by Status

completed4187%
unknown511%
active_not_recruiting12%

Recent Activity

Clinical Trials (47)

Showing 20 of 47 trialsScroll for more
NCT00002462Phase 3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active Not Recruiting
NCT00002889Phase 2

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Completed
NCT00002654Phase 3

Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Completed
NCT00002865Phase 2

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Completed
NCT00002744Phase 3

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
NCT00769548Phase 3

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Completed
NCT00002676Phase 2

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Completed
NCT00002806Phase 2

Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma

Completed
NCT00002494Phase 2

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Completed
NCT00002875Phase 3

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Completed
NCT00002804Phase 2

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

Completed
NCT00002785Phase 2

Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia

Completed
NCT00002618Phase 3

Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

Completed
NCT00002740Phase 1

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma

Completed
NCT00002805Phase 2

Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Completed
NCT00002493Phase 3

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Completed
NCT00767286Phase 3

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Completed
NCT00771641Phase 3

Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck

Completed
NCT00002496Phase 3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

Completed
NCT00002670Phase 3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Completed

Drug Details

Intervention Type
RADIATION
Total Trials
47